Expressions of genes encoding drug-metabolizing enzymes are altered after sevoflurane, isoflurane, propofol or dexmedetomidine anesthesia

Biomedical Research

Volumn 30, Issue 1, 2009, Pages 17-24

  Nakazato, Keiko ^a   Yoshida, Yuko ^a   Takemori, Ken ^a   Kobayashi, Katsuya ^a   Sakamoto, Atsuhiro ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER C2; CARBOXYLESTERASE; CARBOXYLESTERASE 2; CELL NUCLEUS RECEPTOR; CHOLESTEROL 7ALPHA MONOOXYGENASE; CYTOCHROME P450 2B; CYTOCHROME P450 2B15; CYTOCHROME P450 REDUCTASE; DEXMEDETOMIDINE; DRUG METABOLIZING ENZYME; GLUCURONOSYLTRANSFERASE 1A7; ISOFLURANE; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 1A; PROPOFOL; PROTEIN NRLI2; SEVOFLURANE; UNCLASSIFIED DRUG; CYTOCHROME C OXIDASE; NRLI2 PROTEIN;

ANESTHESIOLOGICAL TECHNIQUES; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG CLEARANCE; DRUG METABOLISM; DRUG TRANSPORT; GENE EXPRESSION; GENE IDENTIFICATION; INHALATION ANESTHESIA; INTRAVENOUS ANESTHESIA; LIVER; NONHUMAN; NUCLEOTIDE SEQUENCE; QUANTITATIVE STUDY; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WISTAR RAT; ANESTHETIC RECOVERY; CONTROLLED STUDY; GENE EXPRESSION PROFILING; MALE;

RATTUS;

ANESTHESIA; ANESTHETICS, INHALATION; ANESTHETICS, INTRAVENOUS; ANIMALS; DEXMEDETOMIDINE; GENE EXPRESSION REGULATION; ISOFLURANE; LIVER; MALE; METHYL ETHERS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROPOFOL; RATS; RATS, WISTAR; TIME FACTORS;

EID: 66749084999     PISSN: 0970938X     EISSN: None     Source Type: Journal    
DOI: 10.2220/biomedres.30.17     Document Type: Article

References (38)

1. Bol C, Danhof M, Stanski DR and Mandema JW (1997) Pharmacokinetic-pharmacodynamic characterization of the cardiovascular, hypnotic, EEG and ventilatory responses to dexmedetomidine in the rat. J Pharmacol Exp Ther 283, 1051-1058.
2. Buzaleh AM, Vazquez ES, Nunez G and del Carmen Batlle AM (1997) Effect of chronic anesthesia on the drug-metabolizing enzyme system and heme pathway regulation. Gen Pharmacol 28, 577-582.
3. Carrigan TW and Straughen WJ (1987) A report of hepatic necrosis and death following isoflurane anesthesia. Anesthesiology 67, 581-583.
4. Chu XY, Strauss JR, Mariano MA, Li J, Newton DJ, Cai X, Wang RW, Yabut J, Hartley DP, Evans DC and Evers R (2006) Characterization of mice lacking the multidrug resistance protein MRP2 (ABCC2). J Pharmacol Exp Ther 317, 59-589.
5. Davis M, Eddleston AL, Neuberger JM, Vergani D, Mieli-Vergani G and Williams R (1980) Halothane hepatitis. N Engl J Med 303, 1123-1124.
6. Finn RD, McLaren AW, Carrie D, Henderson CJ and Wolf CR (2007) Conditional deletion of cytochrome P450 oxidore-ductase in the liver and gastrointestinal tract: a new model for studying the functions of the P450 system. J Pharmacol Exp Ther 322, 40-47.
7. Gerlach AT and Dasta JF (2007) Dexmedetomidine: an updated review. Ann Pharmacother 41, 245-252.
8. Gertler R, Brown HC, Mitchell DH and Silvius EN (2001) Dexmedetomidine: a novel sedative-analgesic agent. Proc (Bayl Univ Med Cent) 14, 13-21.
9. Guitton J, Buronfosse T, Desage M, Flinois JP, Perdrix JP, Brazier JL and Beaune P (1998) Possible involvement of multiple human cytochrome P450 isoforms in the liver metabolism of propofol. Br J Anaesth 80, 788-795.
10. Hartley DP, Dai X, He YD, Carlini EJ, Wang B, Huskey SE, Ulrich RG, Rushmore TH, Evers R and Evans DC (2004) Activators of the rat pregnane X receptor differentially modulate hepatic and intestinal gene expression. Mol Pharmacol 65, 1159-1171.
11. Kaivosaari S, Toivonen P, Aitio O, Sipila J, Koskinen M, Salonen JS and Finel M (2008) Regio- and stereospecific N-glucuronidation of medetomidine: the differences between UDP glucuronosyltransferase (UGT) 1A4 and UGT2B10 account for the complex kinetics of human liver microsomes. Drug Metab Dispos 36, 1529-1537.
12. Kast HR, Goodwin B, Tarr PT, Jones SA, Anisfeld AM, Stoltz CM, Tontonoz P, Kliewer S, Willson TM and Edwards PA (2002) Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J Biol Chem 277, 2908-2915.
13. Kharasch ED, Hankins DC, Fenstamaker K and Cox K (2000) Human halothane metabolism, lipid peroxidation, and cytochromes P(450)2A6 and P(450)3A4. Eur J Clin Pharmacol 55, 853-859.
14. Kharasch ED and Thummel KE (1993) Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane. Anesthesiology 79, 795-807.
15. Lavandera JV, Batlle AM and Buzaleh AM (2007) Metabolization of porphyrinogenic agents in brain: involvement of the phase I drug metabolizing system. A comparative study in liver and kidney. Cell Mol Neurobiol 27, 717-729.
16. Levy WJ (1984) Clinical anaesthesia with isoflurane. A review of the multicentre study. Br J Anaesth 56 Suppl 1, 101S-112S.
17. Marik PE (2004) Propofol: therapeutic indications and side-effects. Curr Pharm Des 10, 3639-3649.
18. Mazze RI (1992) The safety of sevoflurane in humans. Anesthesiology 77, 1062-1063.
19. Miyoshi S (1988) Hepatic effects of sevoflurane - changes in the drug-metabolizing enzyme and morphologic features. Masui 37, 414-420. (in Japanese)
20. Nishimura J, Dewa Y, Okamura T, Muguruma M, Jin M, Saegusa Y, Umemura T and Mitsumori K (2008) Possible involvement of oxidative stress in fenofibrate-induced hepatocarcinogenesis in rats. Arch Toxicol 82, 641-654.
21. Njoku D, Laster MJ, Gong DH, Eger EI, 2nd, Reed GF and Martin JL (1997) Biotransformation of halothane, enflurane, isoflurane, and desflurane to trifluoroacetylated liver proteins: association between protein acylation and hepatic injury. Anesth Analg 84, 173-178.
22. Obal D, Preckel B, Scharbatke H, Mullenheim J, Hoterkes F, Thamer V and Schlack W (2001) One MAC of sevoflurane provides protection against reperfusion injury in the rat heart in vivo. Br J Anaesth 87, 905-911.
23. Orth M, Barter L, Dominguez C, Atherley R, Carstens E and Antognini JF (2005) Halothane and propofol differentially affect electroencephalographic responses to noxious stimulation. Br J Anaesth 95, 477-484.
24. Pandak WM, Schwarz C, Hylemon PB, Mallonee D, Valerie K, Heuman DM, Fisher RA, Redford K and Vlahcevic ZR (2001) Effects of CYP7A1 overexpression on cholesterol and bile acid homeostasis. Am J Physiol Gastrointest Liver Physiol 281, G878-G889.
25. Sakamoto A, Imai J, Nishikawa A, Honma R, Ito E, Yanagisawa Y, Kawamura M, Ogawa R and Watanabe S (2005) Influence of inhalation anesthesia assessed by comprehensive gene expression profiling. Gene 356, 39-48.
26. Sawicki WT, Kujawa M, Jankowska-Steifer E, Mystkowska ET, Hyc A and Kowalewski C (2006) Temporal/spatial expression and efflux activity of ABC transporter, P-glycoprotein/Abcb1 isoforms and Bcrp/Abcg2 during early murine development. Gene Expr Patterns 6, 738-746.
27. Servin F, Cockshott ID, Farinotti R, Haberer JP, Winckler C and Desmonts JM (1990) Pharmacokinetics of propofol infusions in patients with cirrhosis. Br J Anaesth 65, 177-183.
28. Servin F, Desmonts JM, Haberer JP, Cockshott ID, Plummer GF and Farinotti R (1988) Pharmacokinetics and protein binding of propofol in patients with cirrhosis. Anesthesiology 69, 887-891.
29. Shelby MK, Cherrington NJ, Vansell NR and Klaassen CD (2003) Tissue mRNA expression of the rat UDP-glucuronosyltransferase gene family. Drug Metab Dispos 31, 326-333.
30. Shichino T, Murakawa M, Adachi T, Arai T, Miyazaki Y and Mori K (1998) Effects of inhalation anaesthetics on the release of acetylcholine in the rat cerebral cortex in vivo. Br J Anaesth 80, 365-370.
31. Shichinohe Y, Masuda Y, Takahashi H, Kotaki M, Omote T, Shichinohe M and Namiki A (1992) A case of postoperative hepatic injury after sevoflurane anesthesia. Masui 41, 1802-1805. (In Japanese)
32. Simons PJ, Cockshott ID, Douglas EJ, Gordon EA, Hopkins K and Rowland M (1988) Disposition in male volunteers of a subanaesthetic intravenous dose of an oil in water emulsion of 14C-propofol. Xenobiotica 18, 429-440.
33. Sinha A, Clatch RJ, Stuck G, Blumenthal SA and Patel SA (1996) Isoflurane hepatotoxicity: a case report and review of the literature. Am J Gastroenterol 91, 2406-2409.
34. Subcommittee on the National Halothane Study of the Committee on Anesthesia NAoS (1966) Summary of the national halothane study. Possible association between halothane anesthesia and postoperative hepatic necrosis. JAMA 197, 775-788.
35. Takemori K, Kobayashi K and Sakamoto A (2008) Expression of pulmonary vasoactive factors after sevoflurane anaesthesia in rats: a quantitative real-time polymerase chain reaction study. Br J Anaesth 100, 190-194.
36. Taketani M, Shii M, Ohura K, Ninomiya S and Imai T (2007) Carboxylesterase in the liver and small intestine of experimental animals and human. Life Sci 81, 924-932.
37. Watanabe K, Hatakenaka S, Ikemune K, Chigyo Y, Kubozono T and Arai T (1993) A case of suspected liver dysfunction induced by sevoflurane anesthesia. Masui 42, 902-905. (In Japanese)
38. Yokooji T, Murakami T, Yumoto R, Nagai J and Takano M (2006) Function of multidrug resistance-associated protein 2 in acute hepatic failure rats. Eur J Pharmacol 546, 152-160.